Kong Fanhui, Chen Yeh-Fong, Jin Kun
Division of Biometrics I, Food and Drug Administration, Silver Spring, Maryland 20993, USA.
J Biopharm Stat. 2009 Nov;19(6):980-1000. doi: 10.1080/10543400903242753.
In clinical trials of drug development, patients are often followed for a certain period of time, and the outcome variables are measured at scheduled time intervals. The main interest of the trial is the treatment efficacy at a prespecified time point, which is often the last visit. In such trials, patient dropout is often the major source for missing data. With possible informative patient dropout, the missing information often causes biases in the inference of treatment efficacy. In this article, for a time-saturated treatment effect model and an informative dropout scheme that depends on the unobserved outcomes only through the random coefficients, we propose a grouping method to correct the biases in the estimation of treatment effect. The asymptotic variance estimator is also obtained for statistical inference. In a simulation study, we compare the new method with the traditional methods of the observed case (OC) analysis, the last observation carried forward (LOCF) analysis, and the mixed model repeated measurement (MMRM) approach, and find it improves the current methods and gives more stable results in the treatment efficacy inferences.
在药物研发的临床试验中,患者通常会被随访一段时间,并且在预定的时间间隔测量结局变量。试验的主要关注点是在预先指定的时间点(通常是最后一次访视)的治疗效果。在这类试验中,患者失访往往是缺失数据的主要来源。由于患者失访可能具有信息性,缺失的信息常常会在治疗效果的推断中导致偏差。在本文中,对于一个时间饱和的治疗效果模型和一个仅通过随机系数依赖于未观察到的结局的信息性失访方案,我们提出一种分组方法来校正治疗效果估计中的偏差。还获得了用于统计推断的渐近方差估计量。在一项模拟研究中,我们将新方法与观察病例(OC)分析、末次观察结转(LOCF)分析和混合模型重复测量(MMRM)方法等传统方法进行比较,发现它改进了现有方法,并且在治疗效果推断中给出了更稳定的结果。